Public Title Status Last Date Modified
A Multi-Center, Randomized, Double Masked and Active Controlled Phase II Study Assessing the Efficacy and Safety of Intravitreal Injections of DE-122 in combination with Lucentis® Compared to Lucenti . . . Ongoing 29 Aug 2018
A multi-center, randomized, double-blind, active-controlled, 8-week study to evaluate the efficacy and safety of LCZ696 in comparison to olmesartan in patients withessential hypertension . . . Completed 11 Mar 2015
A multi-centre, double-blind, randomised, parallel-group, active controlled study to evaluate the efficacy, safety and tolerability of tafenoquine (SB-252263, WR238605) in subjects with Plasmodium viv . . . Pending 13 Nov 2014
A Multi-national, Multi-center, Randomized, Double blinded, Parallel-group Study to Assess the Immunogenicity and Safety of NBP608 Compared to Varivax in Healthy Children 12 Months to 12 Years of Age . . . Ongoing 31 Jan 2017
A multicenter open-label study to evaluate the safety and efficacy of PEG-Intron™ versus PEGASYS™ in subjects with HBeAg positive chronic hepatitis B and HBeAg negative chronic hepatitis B . . . Ongoing 11 Dec 2013
A multicenter study to evaluate safety and tolerability in patients with chronic heart failure and reduced ejection fraction from PARADIGM-HF receiving open label LCZ696 . . . Pending 22 Jun 2015
A Multicenter, Double-Blind, Double-Dummy, Follow-Up Study Evaluating The Long-Term Safety Of Lacosamide (200 To 600mg/Day) In Comparison With Carbamazepine (400 To 1200mg/Day), Used As Monotherapy In . . . Completed 18 Dec 2018
A multicenter, double-blind, double-dummy, randomized, positive-controlled study comparing the efficacy and safety of lacosamide (200 to 600mg/day) to controlled release carbamazepine (400 to 1200mg/d . . . Completed 13 Feb 2017
A Multicenter, Double-Blind, Randomized, Parallel-Group, Phase III Study to Compare the Efficacy and Safety of Hercules Versus Herceptin® in Patients with HER2+Metastatic Breast Cancer . . . Ongoing 04 May 2016
A multicenter, open-label, randomized, event-driven study to assess efficacy, safety and pharmacokinetics of macitentan versus standard of care in children with pulmonary arterial hypertension . . . Pending 19 Apr 2017
A Multicenter, Paired-eye Comparison, Dose-escalation, Single Dose, 24-Month Study of Safety and Efficacy of Bimatoprost Preservative Free lntracameral Drug Delivery System (Bimatoprost PF IC DDS) in . . . Completed 21 Sep 2017
A Multicenter, Phase III, Randomized, Placebo-Controlled Trial to Assess the Safety and Efficacy of MK-3102 Monotherapy in Subjects with Type 2 Diabetes Mellitus and Inadequate Glycemic Control . . . Completed 29 Oct 2015
A multicenter, randomized, double-blind phase 3 study to evaluate tolerability and pharmacokinetics of 500 μg roflumilast once daily with an up-titration regimen in COPD, including an open-label down . . . Completed 22 Jul 2016
A multicenter, randomized, double-blind Phase III trial to evaluate efficacy and safety of BI 695502 plus chemotherapy versus Avastin® plus chemotherapy in patients with advanced nonsquamous Non-Smal . . . Ongoing 06 Mar 2018
A multicenter, randomized, double-blind, placebo controlled phase III study to evaluate the efficacy, safety and tolerability of serelaxin when added to standard therapy in acute heart failure patient . . . Ongoing 11 Mar 2015
A multicenter, randomized, double-blind, placebo-controlled, phase 3 study to evaluate the efficacy and safety, of SA237 as monotherapy in patients with Neuromyelitis Optica (NMO) and Neuromyelitis Op . . . Pending 17 Dec 2018
A Multicenter, Randomized, Open-Label, Phase 3 Trial to Compare the Efficacy and Safety of Lenvatinib (E7080) Versus Sorafenib in First-Line Treatment of Subjects With Unresectable Hepatocellular Carc . . . Completed 25 Oct 2017
A Multicentre Study in Otherwise Healthy Infants and Toddlers Hospitalised For and Diagnosed With RSV Lower Respiratory Tract Infection to Evaluate the Safety, Tolerability, and Clinical Activity of A . . . Completed 17 Aug 2016
A Multinational Study Comparing The Long-term Efficacy And Safety Of Two Medicines, Solifenacin Succinate And Mirabegron Taken Together, Or Separately, Or A Mock Treatment (placebo) In Subjects With S . . . Terminated 05 May 2016
A Phase 1 study to assess the safety and immunogenicity of a new typhoid vaccine compared to current typhoid vaccine in healthy Filipino Adults and Children . . . Completed 04 Jun 2018
A phase 1, single center, double-blind, randomized, placebo-controlled, ascending dose study to investigate the Safety, Tolerability and Pharmacokinetic profiles of single doses of NC-503 in healthy J . . . Completed 20 Dec 2016
A Phase 1b, randomized, partially double-blind, placebo-controlled study to assess the pharmacokinetics, safety, and tolerability of multiple doses of orally administered JNJ-53718678 in infants hospi . . . Terminated 08 Mar 2018
A Phase 3 Clinical Trial to Study Short Duration Versus Standard Response-Guided Therapy with MK-3034 (SCH 503034)/Boceprevir Combined with PegIntron and Ribavirin in Previously Untreated Non- Cirrhot . . . Ongoing 04 Aug 2015
A phase 3 double-blind, randomized, placebo-controlled, parallel-group study to assess the efficacy, safety and tolerability of Bococizumab (PF-04950615) in Asian subjects with Primary Hyperlipidemia . . . Terminated 21 Nov 2016
A Phase 3 Open Label Partially Randomized Trial to Evaluate the Efficacy, Safety and Tolerability of the Combination of Moxifloxacin plus PA-824 plus Pyrazinamide after 4 and 6 months of Treatment in . . . Ongoing 05 May 2016
©2021 HERDIN PLUS. All rights reserved. | Contact Us | Keep up to date